AstronauTx Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $59.4M

  • Investors
  • 9

AstronauTx General Information

Description

Operator of a biotechnology company intended to improve the treatment of Alzheimer's disease and other neurodegenerative diseases. The company specializes in developing new medicines in order to restore the normal behavior of astrocyte patients, enabling healthcare professionals to effectively treat neurotoxicity in the brain caused by dementia.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Holborn Gate
  • 330 High Holborn
  • London WC1V 7QT
  • England, United Kingdom
+44 020
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Holborn Gate
  • 330 High Holborn
  • London WC1V 7QT
  • England, United Kingdom
+44 020

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AstronauTx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 02-Oct-2023 $59.4M Completed Generating Revenue
2. Seed Round 24-Mar-2020 Completed Generating Revenue
1. University Spin-Out 01-Apr-2019 Completed Generating Revenue
To view AstronauTx’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

AstronauTx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to improve the treatment of Alzheimer's disease and other neurodegenerative
Drug Discovery
London, United Kingdom
10 As of 2025

Eysins, Switzerland
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AstronauTx Competitors (54)

One of AstronauTx’s 54 competitors is Asceneuron, a Venture Capital-Backed company based in Eysins, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Asceneuron Venture Capital-Backed Eysins, Switzerland
Neurona Therapeutics Formerly VC-backed South San Francisco, CA
Cytokinetics Formerly VC-backed South San Francisco, CA
Orchard Therapeutics Formerly VC-backed London, United Kingdom
AviadoBio Venture Capital-Backed London, United Kingdom
You’re viewing 5 of 54 competitors. Get the full list »

AstronauTx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AstronauTx Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Brandon Capital Venture Capital Minority
Bristol-Myers Squibb Corporation Minority
EQT Life Sciences Venture Capital Minority
MPM BioImpact Venture Capital Minority
Novartis Venture Fund Corporate Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

AstronauTx FAQs

  • When was AstronauTx founded?

    AstronauTx was founded in 2019.

  • Where is AstronauTx headquartered?

    AstronauTx is headquartered in London, United Kingdom.

  • What is the size of AstronauTx?

    AstronauTx has 10 total employees.

  • What industry is AstronauTx in?

    AstronauTx’s primary industry is Drug Discovery.

  • Is AstronauTx a private or public company?

    AstronauTx is a Private company.

  • What is AstronauTx’s current revenue?

    The current revenue for AstronauTx is .

  • How much funding has AstronauTx raised over time?

    AstronauTx has raised $68.8M.

  • Who are AstronauTx’s investors?

    Brandon Capital, Bristol-Myers Squibb, EQT Life Sciences, MPM BioImpact, and Novartis Venture Fund are 5 of 9 investors who have invested in AstronauTx.

  • Who are AstronauTx’s competitors?

    Asceneuron, Neurona Therapeutics, Cytokinetics, Orchard Therapeutics, and AviadoBio are some of the 54 competitors of AstronauTx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process